Bizarre Patents
User-operated amusement apparatus for kicking the user's buttocks
An apparatus including a user-operated and controlled apparatus for self-infliction of repetitive blows to the user's buttocks by a plurality of elongated arms bearing flexible extensions that rotate under the user's control.
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
US Patent 6579854 - Diagnosis and management of infection caused by chlamydia
US Patent Issued on June 17, 2003
Estimated Patent Expiration Date:
May 6, 2018Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Estimated Patent Expiration Date:
May 6, 2018Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.AbstractThe present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly C. pneumoniae. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.Other References
| InventorsAssigneeApplicationNo. 073661 filed on 05/06/1998US Classes:514/31, The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)514/152, 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI514/192, 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)514/198, Ampicillin per se or salt thereof514/311, Quinolines (including hydrogenated)514/601, Sulfonamides (i.e., Q-(O=)S(=O)-N, wherein Q is a substituent and wherein any substituent attached to the nitrogen will be referred to as E)514/631Amidines (i.e., N=C-N)Field of Search424/114, PLURAL FERMENTATES OF DIFFERENT ORIGIN (E.G., MIXTURES OF ANTIBIOTICS, ETC.)424/263.1, Chlamydia (e.g., Chlamydia trachomatis, etc.)436/518, INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS436/6, Corrosion resistance or power435/7.2, Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate530/389.5, Binds bacterium or similar microorganism or component or product thereof (e.g., Pseudomonas, Chlamydia, Clostridium, bacterium-associated antigen, etc.)530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES536/16.8, Antibiotics536/23.1, DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)536/24.3, Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA536/24.32, Probes for detection of microbial nucleotide sequences514/31, The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.)514/631, Amidines (i.e., N=C-N)514/152, 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI514/192, 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)514/198, Ampicillin per se or salt thereof514/601, Sulfonamides (i.e., Q-(O=)S(=O)-N, wherein Q is a substituent and wherein any substituent attached to the nitrogen will be referred to as E)514/311Quinolines (including hydrogenated)ExaminersPrimary: Weddington, Kevin E.Attorney, Agent or FirmUS Patent References4952594, Reagents and method for therapeutic treatment of multiple sclerosisIssued on: 08/28/1990 Inventor: Mercer5217493, Antibacterial coated medical implants Issued on: 06/08/1993 Inventor: Raad, et al.5424187, Method of screening for arterial chlamydial granuloma Issued on: 06/13/1995 Inventor: Shor, et al.5650405, Treatment for toxoplasmosis with a composition comprising a sulfonamide and a spiropiperidyl derivative of rifamycin S. Issued on: 07/22/1997 Inventor: Remington, et al.5795563, Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment Issued on: 08/18/1998 Inventor: Kallick5880101, Clinical uses of polyene macrolides Issued on: 03/09/1999 Inventor: Stankov6258532Methods for in vitro susceptibility testing of chlamydia Issued on: 07/10/2001 Inventor: Stratton, et al. Foreign Patent References
International ClassesA61K 031/70A61K 031/65 A61K 031/43 A61K 031/47 A61K 031/18 |
